Notice to Expire PAR-25-023, "Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)"
National Institutes of Health (NIH)
About this opportunity
Notice to Expire PAR-25-023, "Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)" Notice Number: NOT-DA-25-042 Key Dates Release Date: November 24, 2025 Related Announcements September 10, 2025 - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional). See NOFO PAR-25-446July 12, 2024 - Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional). See NOFO PAR-25-023 Issued by National Institute on Drug Abuse (NIDA) Purpose The purpose of this Notice is to alert applicants of the early expiration of PAR-25-023, "Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)". The Notice of Funding Opportunity (NOFO), PAR-25-023, will be expir...